Sensex: 83,432.89 (0.01%)

Nifty: 25,461.30 (0.00%)

anubhai angaldas Securities Pvt. Ltd. Member: BSE - NSE - CDSL

Technology . Transparency . Trust

Contact Us
Apply For IPO

MARKET

IPO Synopsis
Windlas Biotech Ltd
Registered Office: 40/1 Mohabewala Industrial, Area, Dehradun - 248110, Uttarakhand
Phone: 1
Email: 1
Website: 1
Initial Public Offer of 8,729,023* equity shares of face value of Rs.5 each ("equity shares") of Windlas Biotech Limited ("company" Rs.455 per equity share) aggregating to Rs.401.54 Crores (the "offer") comprising a fresh issue of 3,586,956* equity shares aggregating to Rs.165 Crores (the "fresh issue") and an offer for sale of 5,142,067* equity shares, comprising of 1,136,000* equity shares aggregating to Rs.52.26* Crores by Vimla Windlass (the "individual selling shareholder") and 4,006,067* equity shares aggregating to Rs.184.28* Crores by Tano India Private Equity Fund II (the "investor selling shareholder", and collectively with the individual selling shareholder, the "selling shareholders", and such equity shares, the "offered shares") aggregating to Rs.236.54 Crores (the "offer for sale). The offer constitutes 40.05% of the post-offer paid-up equity share capital of the Company. The face value of equity shares is Rs.5 each. The offer price is Rs.460 per equity share and is 92 times the face value of the equity shares. *subject to finalisation of the basis of allotment.
Issue Money Payable On
Opens On Closes On Application Allotment
04-Aug-2021 06-Aug-2021 460.00 - 0.00 0.00 - 0.00
Cr. Lead Managers to the Issue
Project Cost 165.00
Project Financed through Current Offer 401.54
Post Issue Equity Share Capital 10.90
Issue Price 460.00
Projects
Purchase of Equipment required for (i) Capacity Expansion of the existing facility at the Dehradun Plant-IV and (II) Addition of Injectables Dosage Capability at the existing facility at Dehradun Plant - II
Funding Incremental Working Capital Requirements of the Company
Repayment/Prepayment of certain of the Borrowings
General Corporate Purposes
Promoted By
Ashok Kumar Windlass
Hitesh Windlass
Manoj Kumar Windlass
BSE
NSE
Registrar to the Issue
Attention Investor
As per CDSL communiqué Kindly update your Email ID, Mobile Number & Income Range in CDSL demat Account on or before 31st May 2021, Non Compliance Account will be INACTIVE after 31st May 2021. | Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.  | "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." | "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."    Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of Investors.